Health economics

This programme of work examines the impact of COVID-19 on the economy. We look at the cost-effectiveness of the measures introduced to control the virus and estimate the burden on healthcare facilities in real-time.

Key activities include:

• Applying statistical methods to estimate the burden of COVID-19 under various scenarios of spread and severity and the associated demands on healthcare resources (hospital beds, consultations).
• Monitoring and analysing the impact of COVID-19 - and the measures put in place to control it - on financial markets and the wider economy, including aspects such as: productivity loss and changes in consumption.
• Addressing the question: which measures are most effective in reducing cases, hospital admissions and deaths from COVID-19?

• Led by UAntwerp: Indications for healthcare surge capacity in European countries facing an exponential increase in coronavirus disease (COVID-19) cases, March 2020
• Led by LSHTM: The impact of Covid-19, associated behaviours and policies on the UK economy: A computable general equilibrium model
• Led by LSHTM: The potential health and economic value of SARS-CoV-2 vaccination alongside physical distancing in the UK: transmission model-based future scenario analysis and economic evaluation
• Led by UAntwerp: Ceci n'est pas un lit. Base capacity healthcare matters in a pandemic
• Led by LSHTM and UAntwerp: Multi-country collaboration in responding to global infectious disease threats: lessons for Europe from the COVID-19 pandemic - The Lancet Regional Health – Europe
• Led by LSHTM: Long-term health-related quality of life in non-hospitalised COVID-19 cases with confirmed SARS-CoV-2 infection in England: Longitudinal analysis and cross-sectional comparison with controls
• Led by UAntwerp: Individual factors influencing COVID-19 vaccine acceptance in between and during pandemic waves (July–December 2020)
• Led by UAntwerp: A look into the future of the COVID-19 pandemic in Europe: an expert consultation
• Led by LSHTM: Optimal health and economic impact of non-pharmaceutical intervention measures prior and post vaccination in England: a mathematical modelling study
• Led by UAntwerp: The burden of isolation to the individual: a comparison between isolation for COVID-19 and for other influenza-like illnesses in Japan
• Led by UAntwerp: Impact of long-COVID on health-related quality of life in Japanese COVID-19 patients
• Led by LSHTM and UAntwerp: How can early stage economic evaluation help guide research for future vaccines?
• Led by UAntwerp: Towards a European strategy to address the COVID-19 pandemic
• Led by UAntwerp: Determinants of basic childhood vaccination coverage in European and OECD countries
• Led by UAntwerp and LSHTM: Placing a value on increased flexible vaccine manufacturing capacity for future pandemics

The health economics workstream is led by the University of Antwerp and supported by LSHTM.